Case fatality associated with a hypervirulent strain in patients with culture-positive Clostridium difficile infection: A retrospective population-based study

International Journal of Infectious Diseases

Volumn 16, Issue 7, 2012, Pages

  Huttunen, Reetta ^a,b   Vuento, Risto ^b,c   Syrjänen, Jaana ^a,b   Tissari, Päivi ^d   Aittoniemi, Janne ^b,c  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF TAMPERE MEDICAL SCHOOL   (Finland)

^c PIRKANMAA HOSPITAL DISTRICT   (Finland)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Biomarker; Case fatality; Clostridium difficile; Hypervirulent; Prognosis; Strain

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; DISEASE ASSOCIATION; FEMALE; FINLAND; HUMAN; HUMAN CELL; HYPERVIRULENT CLOSTRIDIUM DIFFICILE INFECTION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; POPULATION RESEARCH; PROGNOSIS; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; SURVIVOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; FINLAND; HUMANS; LEUKOCYTE COUNT; LOGISTIC MODELS; MALE; MIDDLE AGED; MORTALITY; PROGNOSIS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84862559760     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2012.02.019     Document Type: Article

References (18)

1. Kazakova S.V., Ware K., Baughman B., Bilukha O., Paradis A., Sears S., et al. A hospital outbreak of diarrhea due to an emerging epidemic strain of Clostridium difficile. Arch Intern Med 2006, 166:2518-2524.
2. Morgan O.W., Rodrigues B., Elston T., Verlander N.Q., Brown D.F., Brazier J., et al. Clinical severity of Clostridium difficile PCR ribotype 027: a case-case study. PLoS One 2008, 3:e1812.
3. Khanna S., Pardi D.S. The growing incidence and severity of Clostridium difficile infection in inpatient and outpatient settings. Expert Rev Gastroenterol Hepatol 2010, 4:409-416.
4. O'Donoghue C., Kyne L. Update on Clostridium difficile infection. Curr Opin Gastroenterol 2011, 27:38-47.
5. Hubert B., Loo V.G., Bourgault A.M., Poirier L., Dascal A., Fortin E., et al. A portrait of the geographic dissemination of the Clostridium difficile North American pulsed-field type 1 strain and the epidemiology of C. difficile-associated disease in Quebec. Clin Infect Dis 2007, 44:238-244.
6. Miller M., Gravel D., Mulvey M., Taylor G., Boyd D., Simor A., et al. Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality. Clin Infect Dis 2010, 50:194-201.
7. Goorhuis A., Van der Kooi T., Vaessen N., Dekker F.W., Van den Berg R., Harmanus C., et al. Spread and epidemiology of Clostridium difficile polymerase chain reaction ribotype 027/toxinotype III in The Netherlands. Clin Infect Dis 2007, 45:695-703.
8. Kotila S.M., Virolainen A., Snellman M., Ibrahem S., Jalava J., Lyytikainen O. Incidence, case fatality and genotypes causing Clostridium difficile infections, Finland, 2008. Clin Microbiol Infect 2011, 17:888-893.
9. Official Statistics of Finland (OSF). Population structure. Helsinki: Statistics Finland; 2011. Available at: (accessed October 2011). http://www.stat.fi/til/vrm_en.html.
10. Barbut F., Mastrantonio P., Delmee M., Brazier J., Kuijper E., Poxton I. Prospective study of Clostridium difficile infections in Europe with phenotypic and genotypic characterisation of the isolates. Clin Microbiol Infect 2007, 13:1048-1057.
11. Antikainen J., Pasanen T., Mero S., Tarkka E., Kirveskari J., Kotila S., et al. Detection of virulence genes of Clostridium difficile by multiplex PCR. APMIS 2009, 117:607-613.
12. Loo V.G., Bourgault A.M., Poirier L., Lamothe F., Michaud S., Turgeon N., et al. Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med 2011, 365:1693-1703.
13. Ausiello C.M., Cerquetti M., Fedele G., Spensieri F., Palazzo R., Nasso M., et al. Surface layer proteins from Clostridium difficile induce inflammatory and regulatory cytokines in human monocytes and dendritic cells. Microbes Infect 2006, 8:2640-2646.
14. Spigaglia P., Barbanti F., Mastrantonio P. Surface layer protein A variant of Clostridium difficile PCR-ribotype 027. Emerg Infect Dis 2011, 17:317-319.
15. Pepin J., Valiquette L., Alary M.E., Villemure P., Pelletier A., Forget K., et al. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ 2004, 171:466-472.
16. Cohen S.H., Gerding D.N., Johnson S., Kelly C.P., Loo V.G., McDonald L.C., et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010, 31:431-455.
17. Bartlett J.G., Perl T.M. The new Clostridium difficile-what does it mean?. N Engl J Med 2005, 353:2503-2505.
18. Enoch D.A., Butler M.J., Pai S., Aliyu S.H., Karas J.A. Clostridium difficile in children: colonisation and disease. J Infect 2011, 63:105-113.